awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33429873-59C43989-5A95-43B6-8CA9-C65D9CCD0D9C
Q33429873-59C43989-5A95-43B6-8CA9-C65D9CCD0D9C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33429873-59C43989-5A95-43B6-8CA9-C65D9CCD0D9C
A Multi-Institution Phase I Trial of Ruxolitinib in Patients with Chronic Myelomonocytic Leukemia (CMML)
P2860
Q33429873-59C43989-5A95-43B6-8CA9-C65D9CCD0D9C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33429873-59C43989-5A95-43B6-8CA9-C65D9CCD0D9C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1c1f942035d54ac6b5e02705d474bdda1ed26d88
P2860
Results of a phase 2 study of pacritinib (SB1518), a JAK2/JAK2(V617F) inhibitor, in patients with myelofibrosis.